Drug intelligence / Profile preview

3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is a synthetic small molecule with the chemical formula C20H14BrN5O and a molecular weight of approximately 420.26 g/mol. It belongs to the class of bromodiphenyl ethers and features a pyrazolo[3,4-c]pyridazine core structure. The compound is listed as experimental and has not been approved for any medical use or entered clinical trials as of now. There is no available information on its mechanism of action, biological targets, or therapeutic indications in public databases. Its primary relevance appears to be in chemical biology or medicinal chemistry research rather than as an established pharmaceutical agent.[1][2][3][9]

Other names: 3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile

Beyond the preview

Go deeper on 3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile.

Explore the full profile